Member Info for BuenaVista

Slightly more plausible than Alan's dog ate the data.

Timster is our very own Russian bot.

Hmm... not sure I totally trust Hurstbot. I had a look and it said LEGO on the lid.

I'm going for the recs and say that DTW is absolutely correct. He knows exactly what's what. It's as clear as the day is long. This is GOOD news for us, the SP, the company and future patients!

The footnotes are sloppily written, as if they are typed out anew each time. Why don't they use saved blocks of text, or at least take a couple of minutes to proof-read before issuing? It doesn't look good when they can't find the ™ combo (Alt+0153). A minor point you might think, but an all too common occurrence in RNSes. And in presentation slides, where the nature of AVA3996 changes from presentation to presentation and the Science Day was given as both September 2022 and November 2022 in the AGM slides.

19th December:
Avacta's Therapeutics Division, a clinical stage oncology drug innovator, is building a wholly owned pipeline of novel Affimer® immunotherapies and pre|CISIONTM tumour targeted chemotherapies.
...
Avacta's Diagnostics Division develops and supplies a broad range of in-vitro diagnostic (IVD) solutions for healthcare professionals and consumers. The Division is...

Today:
Avacta's Therapeutics Division, a clinical stage oncology drug innovator, is building a wholly owned pipeline of novel Affimer immunotherapies and pre||CISION tumour targeted chemotherapies.
...
Avacta's Diagnostics Division develops and supplies a broad range of in-vitro diagnostic (IVD) solutions for healthcare professionals and consumers The Division is...

Goldieloc13, it took me about a minute to find this page of posts. Not saying there isn't any BS in DD77's post but you should try doing this first.

https://www.lse.co.uk/profiles/dd77/?page=63

Beware both groups.

Exercise critical judgement.

Both groups trade.

Beware the twitterampati

Maybe with the markets closed in the US there will be more airtime for foreign markets' news?

It's mice metis
https://www.google.com/search?q=pdx+model+meaning

Specifically this
https://www.championsoncology.com/translational-research/solid-tumor-pdx-models

We don't know Bella. Hopefully SZ can tell us.

SZ, you should DEFINATELY hold of buyin g in until your,se RNS comes threw

It is often quoted that FAP is upregulated in tumours, etc compared to healthy ADULT tissue.

https://www.google.com/search?q=Fibroblast+fap+%22adult+tissue%22

Worth asking Alan when the age cut-off is if we get the chance.

And there was me looking at secondhand car prices.

No, it came from here originally.

However, one correction: the CAS number is 1841402-73-0

You're brave! The BB guard dogs tried to crucify me for raising the issue of contraindications, even though these were clearly there in the patent as alternative conditions that could be treated. Speaking of which, the platform, if proven to work, might also be amenable to being used to target antiarthritic, antifibrotic, anti-inflammatory, etc drugs to treat arthritis, fibrosis, inflammation, etc. - all huge revenue streams.

The OTHER Ruth Plummer (Freemans affiliated rather than National Cancer Research Institute) with a photo of the lady. Trial data is the same, different ratings.

Avacta will need to have a very clear, substantiated handle on what the pre|CISION substrates are worth in order hold their negotiating position. You can guarantee that the pharma majors will have their own substantiated figures to hand which will be considerably lower than Avacta's!

Doc, have you 'lost' or 'sunk' a small fortune in Avacta? There is a difference!

----

Thinking about this 'early January' a bit more, I now think that any delay in the trial update (and there is technically no delay as yet) is either due to an unrealistic self-imposed deadline, an unexpected event or, as I now suspect and certainly hope, the 'early January' was a negotiating tactic to speed licensing agreements with major pharma companies. I hope this last one because that's the best and probably the only way to get several of these drugs approved for use quickly.

No offence taken. (What was the post?!)